6 Results for "

PET-cGMP

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "PET-cGMP" in MCE Product Catalog:

Cat. No.: HY-137665
CAS No.: 78080-27-0
Target:  

PKG

Research Areas:  

Cardiovascular Disease

PET-cGMP is a cyclic guanosine monophosphate analog and an effective selective agonist of PKG I, the EC50 of PET-cGMP for PKG Iβ is 3.8 nM, while for PKG II, it's 193 nM .
loading...
    loading...
Cat. No.: HY-108548
CAS No.: 185246-32-6
Synonyms: Rp-8-Bromo-PET-cGMPS
Target:  

PKG

Research Areas:  

Inflammation/Immunology

Rp-8-Br-PET-cGMPS sodium (Rp-8-Bromo-PET-cGMPS) is an analog of cyclic GMP (cGMP). It is a cell permeable, competitive, and reversible inhibitor of cGMP-dependent protein kinases (cGKs) that blocks activation of cGKI and cGKII by cGMP (Kis=35 and 30 nM). It less potently inhibits protein kinase A (Ki=11 μM) and cGMP-induced activation of cyclic nucleotide-gated channels (IC50=25 μM). In the absence of cGMP stimulation, Rp-8-bromo-PET-cGMPS can act as a partial agonist of cGKI (Ki=1 μM). Rp-8-bromo-PET-cGMPS is resistant to hydrolysis by phosphodiesterase 11.
loading...
    loading...
Cat. No.: HY-137378A
CAS No.: 144510-04-3
Target:  

PKG

8-Br-PET-cGMP is an agonist of cGMP-dependent protein kinase type I (cGKI). 8-Br-PET-cGMP promotes the dimerization of cGKI and activates its catalytic activity by binding to the regulatory domain of cGKI. 8-Br-PET-cGMP can be used to study the role of cGMP signaling pathways in cell growth, vasodilation, and smooth muscle cell function .
loading...
    loading...
Cat. No.: HY-137629
CAS No.: 1262749-63-2
Target:  

PKG

Research Areas:  

Cardiovascular Disease

Sp-8-pCPT-PET-cGMPS is an activator for PKG-I. Sp-8-pCPT-PET-cGMPS can be used for research of NO/NOS/sGC/PKG-I signaling pathway in cardiac differentiation .
loading...
    loading...
Cat. No.: HY-137633
CAS No.: 172806-21-2
Target:  

PKG

Research Areas:  

Neurological Disease

Sp-8-Br-PET-cGMPS is a membrane-permeable PKG agonist and a membrane-permeable inhibitor of retinal-type cGMP-gated ion channels, as well as an activator of cGMP-dependent protein kinases I α and I β. Sp-8-Br-PET-cGMPS is resistant to mammalian cyclic nucleotide-dependent phosphodiesterases, has no metabolic side effects, and is more lipophilic and permeable than Sp-8-pCPT-cGMPS. Sp-8-Br-PET-cGMPS can be used to study the role of cGMP signaling pathways in the nervous system .
loading...
    loading...
Cat. No.: HY-187175
CAS No.: 2172940-88-2
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

Rp-8-Br-pME-PET-cGMPS is a cGMP (HY-113469) analog. Rp-8-Br-pME-PET-cGMPS is used for research on retinal dystrophy, retinitis pigmentosa, Stargardt disease, and macular degeneration .
loading...
    loading...